METROPOLITAN LIFE INSURANCE CO/NY - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 131 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$350,858
+121.5%
9,3140.0%0.01%
+150.0%
Q4 2020$158,431
+97.8%
9,314
-29.9%
0.00%
+100.0%
Q2 2019$80,096
-55.0%
13,2830.0%0.00%
-66.7%
Q1 2019$177,992
+44.1%
13,2830.0%0.00%
+50.0%
Q4 2018$123,532
-33.2%
13,2830.0%0.00%
-33.3%
Q3 2018$184,899
-99.9%
13,2830.0%0.00%0.0%
Q2 2018$210,004,000
+26.3%
13,283
+37.2%
0.00%
+50.0%
Q1 2018$166,285,000
+83882.3%
9,679
+7.0%
0.00%
-33.3%
Q4 2017$198,000
-75.0%
9,044
-53.2%
0.00%
-40.0%
Q3 2017$791,000
+35.9%
19,3330.0%0.01%
+25.0%
Q2 2017$582,000
-16.7%
19,3330.0%0.00%
-20.0%
Q1 2017$699,000
-27.9%
19,3330.0%0.01%
-28.6%
Q4 2016$969,000
-7.1%
19,333
-2.7%
0.01%
-12.5%
Q3 2016$1,043,000
+26.9%
19,8750.0%0.01%
+33.3%
Q2 2016$822,000
+12.6%
19,875
+10.6%
0.01%0.0%
Q1 2016$730,000
+13.2%
17,967
+15.6%
0.01%
+20.0%
Q4 2015$645,000
+176.8%
15,537
+2.8%
0.01%
+150.0%
Q3 2015$233,000
-38.0%
15,1170.0%0.00%
-33.3%
Q2 2015$376,000
+16.8%
15,117
+7.2%
0.00%
+50.0%
Q1 2015$322,000
-15.5%
14,1050.0%0.00%
-33.3%
Q4 2014$381,000
+130.9%
14,1050.0%0.00%
+200.0%
Q3 2014$165,000
-24.7%
14,1050.0%0.00%
-50.0%
Q2 2014$219,00014,1050.00%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
BVF INC/IL 3,381,117$47,065,0004.14%
GREAT POINT PARTNERS LLC 1,647,753$22,937,0003.58%
Rock Springs Capital Management LP 598,000$8,324,0000.30%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 136,029$1,894,0000.14%
FOX RUN MANAGEMENT, L.L.C. 20,935$291,0000.13%
Hilltop Holdings Inc. 39,824$554,0000.12%
WEXFORD CAPITAL LP 112,700$1,569,0000.10%
OXFORD ASSET MANAGEMENT LLP 296,339$4,132,0000.09%
Vident Investment Advisory, LLC 133,272$1,855,0000.07%
ALTRINSIC GLOBAL ADVISORS LLC 90,000$1,253,0000.06%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders